Risk of changes to and tighter regulation of clinical testing-related laws and regulations
First written in FY2016. 15 of 16 entries say "Restated". Latest entry: FY2025.
2 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「If relevant laws are amended or regulations are strengthened in the future, compliance could restrict the activities of the Group and lead to higher costs.」
Continues to identify restrictions on activities and higher costs resulting from amendments to or tighter regulation of clinical testing-related laws and regulations as risks. - FY2023-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
States that there have been no material changes to the risk of changes to or tighter regulation of clinical testing-related laws and regulations described in the previous fiscal year. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
States that there have been no material changes to the risk of changes to or tighter regulation of clinical testing-related laws and regulations described in the previous fiscal year. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
States that there have been no material changes to the risk of changes to or tighter regulation of laws and regulations described in the previous fiscal year. - FY2019RestatedAnnual report
「If this law or related regulations are amended or strengthened in the future, compliance could restrict the activities of the Group and lead to higher costs.」
Continues to identify restrictions on activities and higher costs resulting from changes to or tighter regulation under the Act on Clinical Laboratory Technicians and related personnel as risks. - FY2019-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
States that there have been no material changes to the risk of changes to or tighter regulation of laws and regulations described in the previous fiscal year. - FY2019-Q2RestatedAnnual report
「During the cumulative second quarter of the current fiscal year, there were no material changes in the financial position, operating results or cash flow, including any abnormal fluctuations, or in the “Business and Other Risks” described in the annual securities report for the previous fiscal year. There are also no material events or similar matters.」
States that there have been no material changes to the risk of changes to or tighter regulation of laws and regulations described in the previous fiscal year. - FY2019-Q1RestatedAnnual report
「During the cumulative first quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
Explicitly states that there have been no material changes to the business and other risks described in the previous fiscal year. - FY2018-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
Explicitly states that there have been no material changes to the business and other risks described in the previous fiscal year. - FY2018-Q2RestatedAnnual report
「During the cumulative second quarter of the current fiscal year, there were no material changes in the financial position, operating results or cash flow, including any abnormal fluctuations, or in the “Business and Other Risks” described in the annual securities report for the previous fiscal year. There are also no material events or similar matters.」
Explicitly states that there have been no material changes to the business and other risks described in the previous fiscal year. - FY2018-Q1RestatedAnnual report
「During the cumulative first quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
Explicitly states that there have been no material changes to the business and other risks described in the previous fiscal year. - FY2017RestatedAnnual report
「If this law or related regulations are amended or strengthened in the future, compliance could restrict the activities of the Group and lead to higher costs.」
Continues to identify restrictions on activities and higher costs resulting from changes to or tighter regulation under the Act on Clinical Laboratory Technicians and related personnel as risks. - FY2017-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
Explicitly states that there have been no material changes to the business and other risks described in the previous fiscal year. - FY2017-Q2RestatedAnnual report
「During the cumulative second quarter of the current fiscal year, there were no material changes in the financial position, operating results or cash flow, including any abnormal fluctuations, or in the “Business and Other Risks” described in the annual securities report for the previous fiscal year. There are also no material events or similar matters.」
Explicitly states that there have been no material changes to the business and other risks described in the previous fiscal year. - FY2017-Q1RestatedAnnual report
「During the cumulative consolidated period of the first quarter, there were no material changes in unusual fluctuations, etc., in financial position, operating results or cash flows, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
Explicitly states that there have been no material changes to the business and other risks described in the previous fiscal year. - FY2016First statedAnnual report
「If this law or related regulations are amended or strengthened in the future, compliance could restrict the activities of the Group and lead to higher costs.」
Identifies restrictions on activities and higher costs resulting from changes to or tighter regulation under the Act on Clinical Laboratory Technicians and related personnel as risks.